Premium
[P2–544]: CONCOMITANT USE OF ANTICHOLINERGIC MEDICATION ATTENUATES BENEFITS OF CHOLINESTERASE INHIBITORS IN ALZHEIMER's DISEASE: A LARGE COHORT STUDY OF SURVIVAL AND COGNITIVE FUNCTION
Author(s) -
Mueller Christoph,
Stubbs Brendon,
Banerji Shriya,
Stewart Robert,
Perera Gayan
Publication year - 2017
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2017.06.1202
Subject(s) - cognitive decline , dementia , medicine , cohort , rivastigmine , confounding , concomitant , mini–mental state examination , cognition , anticholinergic , clinical dementia rating , donepezil , logistic regression , psychiatry , disease
Figure. Comparison of longitudinal change in MMSE Babak Hooshmand, Helga Refsum, A. David Smith, Ingemar K areholt, Christine von Arnim, Erika Jonsson Laukka, Lars B€ackman, Laura Fratiglioni, Miia Kivipelto, Karolinska Institutet, Stockholm, Sweden; Ulm University Hospital, Ulm, Germany; Oslo University, Oslo, Norway; Oxford University, Oxford, United Kingdom; Karolinska Institute, Stockholm, Sweden; Stockholm Gerontology Research Center, Stockholm, Sweden; Kuopio University Hospital, Kuopio, Finland; National Institute for Health and Welfare, Helsinki, Finland; Karolinska Institutet-Stockholm University, Stockholm, Sweden; University of Eastern Finland, Kuopio, Finland. Contact e-mail: Babak.Hooshmand@ki.se